Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000905443 | SCV001050028 | likely benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004678863 | SCV005180716 | uncertain significance | Inborn genetic diseases | 2024-05-15 | criteria provided, single submitter | clinical testing | The c.2647G>A (p.A883T) alteration is located in exon 20 (coding exon 19) of the UNC45B gene. This alteration results from a G to A substitution at nucleotide position 2647, causing the alanine (A) at amino acid position 883 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000905443 | SCV005214656 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003950648 | SCV004760307 | benign | UNC45B-related disorder | 2020-06-05 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |